Differences in Functional Level and Central Symptom of Network Structures in the Patients Seeking Treatment for Panic Disorder Before and During the COVID-19 Pandemic
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Mental health problems such as anxiety, panic, and depression have been exacerbated by the coronavirus disease-2019 (COVID-19). This study aimed to compare the symptom severities and overall function before and during the COVID-19 pandemic among patients with panic disorder (PD) seeking treatment compared to healthy controls (HCs).Methods Baseline data were collected from the two groups (patients with PD and HCs) in two separate periods: before COVID-19 (Jan 2016–Dec 2019) and during COVID-19 (Mar 2020–Jul 2022). A total 453 participants (before COVID-19: 246 [139 patients with PD and 107 HCs], during COVID-19: 207 [86 patients with PD and 121 HCs]) was included. Scales for panic and depressive symptoms and overall function were administered. Additionally, network analyses were performed to compare the two groups within the patients with PD.Results The results of two-way analysis of variance analyses showed that patients with PD enrolled during COVID-19 showed higher levels of interoceptive fear and lower overall functioning. In addition, a network comparison test revealed that a significantly high strength and expected influence for agoraphobia and avoidance in patients with PD during COVID-19.Conclusion This study suggested that the overall function could have worsened, and the importance of agoraphobia and avoidance as a central symptom may have increased in patients with PD seeking treatment during COVID-19.
Abstract
Objective Mental health problems such as anxiety, panic, and depression have been exacerbated by the coronavirus disease-2019 (COVID-19). This study aimed to compare the symptom severities and overall function before and during the COVID-19 pandemic among patients with panic disorder (PD) seeking treatment compared to healthy controls (HCs).Methods Baseline data were collected from the two groups (patients with PD and HCs) in two separate periods: before COVID-19 (Jan 2016–Dec 2019) and during COVID-19 (Mar 2020–Jul 2022). A total 453 participants (before COVID-19: 246 [139 patients with PD and 107 HCs], during COVID-19: 207 [86 patients with PD and 121 HCs]) was included. Scales for panic and depressive symptoms and overall function were administered. Additionally, network analyses were performed to compare the two groups within the patients with PD.Results The results of two-way analysis of variance analyses showed that patients with PD enrolled during COVID-19 showed higher levels of interoceptive fear and lower overall functioning. In addition, a network comparison test revealed that a significantly high strength and expected influence for agoraphobia and avoidance in patients with PD during COVID-19.Conclusion This study suggested that the overall function could have worsened, and the importance of agoraphobia and avoidance as a central symptom may have increased in patients with PD seeking treatment during COVID-19.
참고문헌 (37)
- "WHO announces COVID-19 outbreak a pandemic"[URL]
- Rogers JP, "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections : a systematic review and meta-analysis with comparison to the COVID-19 pandemic", Lancet Psychiatry, 7, pp.611~627 (2020)
- Troyer EA, "Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms", Brain Behav Immun, 87, pp.34~39 (2020)
- Tsamakis K, "COVID-19 and its consequences on mental health", Exp Ther Med, 21, pp.244~ (2021)
- Tsamakis K, "COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment", Exp Ther Med, 20, pp.159~162 (2020)
- Mosolova ES, "Stress, anxiety, depression and burnout in healthcare workers during the first two outbreaks of COVID-19 in Russia", Zh Nevrol Psikhiatr Im S S Korsakova, 122, pp.128~133 (2022)
- Lee Hoo-yeon, "Depression, anxiety, and stress in Korean general population during the COVID-19 pandemic", Epidemiology and Health, 44, pp.1~8 (2022), 한국역학회[DOI]
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision (DSM-5-TR)" (2022), American Psychiatric Association Publishing
- Bhatia MS, "COVID-19 pandemic-induced panic disorder", Prim Care Companion CNS Disord, 22, pp.26177~ (2020)
- Georgieva I, "Prevalence, new incidence, course, and risk factors of PTSD, depression, anxiety, and panic disorder during the COVID-19 pandemic in 11 countries", Healthcare(Basel), 9, pp.664~ (2021)
- Bai W, "Network analysis of anxiety and depressive symptoms among nursing students during the COVID-19 pandemic", J Affect Disord, 294, pp.753~760 (2021)
- Cai H, "Network analysis of depressive and anxiety symptoms in adolescents during the later stage of the COVID-19 pandemic", Transl Psychiatry, 12, pp.98~ (2022)
- Shear MK, "Standardized assessment for panic disorder research. A conference report", Arch Gen Psychiatry, 51, pp.346~354 (1994)
- Brown TA, "A psychometric reanalysis of the albany panic and phobia questionnaire", Behav Res Ther, 43, pp.337~355 (2005)
- 김지혜, "한국판 알마니 공황-공포 질문지 타당화 연구", 신경정신의학, 43(3), pp.329~336 (2004), 대한신경정신의학회
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Dozois DJ, "A psychometric evaluation of the Beck Depression Inventory–II", Psychol Assess, 10, pp.83~ (1998)
- 유병관, "한국어판 벡 우울 설문지 2판의 신뢰도 및 요인분석 : 대학생을 대상으로", 생물정신의학, 18(3), pp.126~133 (2011), 대한생물정신의학회
- Lim YJ, "Korean anxiety sensitivity index-revised : its factor structure, reliability, and validity in clinical and nonclinical samples", Depress Anxiety, 24, pp.331~341 (2007)
- Taylor S, "An expanded anxiety sensitivity index : evidence for a hierarchic structure in a clinical sample", J Anxiety Disord, 12, pp.463~483 (1998)
- Leon AC, "Assessing impairment in patients with panic disorder : the Sheehan Disability Scale", Soc Psychiatry Psychiatr Epidemiol, 27, pp.78~82 (1992)
- Leon AC, "Assessing psychiatric impairment in primary care with the Sheehan Disability Scale", Int J Psychiatry Med, 27, pp.93~105 (1997)
- R Core Team, "R: a language and environment for statistical computing", R Foundation for Statistical Computing, ~ (2013)
- Lauritzen SL, "Graphical models" (1996), Oxford University Press
- Epskamp S, "qgraph : network visualizations of relationships in psychometric data", J Stat Softw, 48, pp.1~18 (2012)
- Epskamp S, "Estimating psychological networks and their accuracy : a tutorial paper", Behav Res Methods, 50, pp.195~212 (2018)
- Borgatti SP, "Centrality and network flow", Soc Networks, 27, pp.55~71 (2005)
- Opsahl T, "Node centrality in weighted networks : generalizing degree and shortest paths", Soc Networks, 32, pp.245~251 (2010)
- Chernick MR, "Bootstrap methods : a guide for practitioners and researchers" (2011), John Wiley & Sons
- Costenbader E, "The stability of centrality measures when networks are sampled", Soc Networks, 25, pp.283~307 (2003)
- Epskamp S, "A tutorial on regularized partial correlation networks", Psychol Methods, 23, pp.617~634 (2018)
- van Borkulo CD, "Comparing network structures on three aspects : a permutation test", Psychol Methods (2022)[DOI]
- Dalege J, "Network analysis on attitudes : a brief tutorial", Soc Psychol Personal Sci, 8, pp.528~537 (2017)
- Breen LJ, "Psychological risk factors of functional impairment after COVID-19 deaths", J Pain Symptom Manage, 61, pp.e1~e4 (2021)
- Gallagher MW, "The impact of COVID-19 experiences and associated stress on anxiety, depression, and functional impairment in American adults", Cognit Ther Res, 44, pp.1043~1051 (2020)
- Czeisler MÉ, "Delay or avoidance of medical care because of COVID-19–related concerns—United States, June 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1250~1257 (2020)
- Shamblaw AL, "Coping during the COVID-19pandemic : relations with mental health and quality of life", Can Psychol, 62, pp.92~ (2021)
